To request a FREE 2-week trial subscription, please signup. NOTE - this can take up to 48hrs to be approved.

13 June 2024 Biotech takes legal action against Tempus AI, alleging patent infringement in Tempus's liquid biopsy products | Complaint accuses Tempus of unauthorised use of Guardant's tech crucial for ...

21 January 2025 New president says repeal is first of “many steps the US federal government will take to repair our ...

John Squires’ IP monetisation history offers clues to his interests, but supporters say his focus on business and innovation ...

Return-to-office orders, redundancies, hiring freezes—do changes sweeping through the US agency ‘risk breaking the system’?

The ex-Cadwell Clonts Reeder & Thomas trial attorney and litigator represents clients in all phases of litigation in both ...

New York biotech scores win as Fed Circ upholds preliminary injunction against Celltrion's biosimilar launch | Ruling follows ...

As IP professionals wait for agency cutbacks to be felt down the chain, the advice is to stay informed, manage budgets wisely, and use a mix of protections to weather any disruption, finds Marisa ...

If you don't have a login or your access has expired, you will need to purchase a subscription to gain access to this article, including all our online content.

The multinational claims Mylan Pharmaceuticals’ generic of its blockbuster weight loss drug infringes another new patent | Complaint similar but separate to previous lawsuit against Mylan and Sun ...